INCEPTIONR LLC: STRA position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of INCEPTIONR LLC on STRA, newest first. How the timeline and the estimate are built.
INCEPTIONR LLC held 4,930 STRA shares at 2026-06-30 per its 13F-HR filed 2026-08-11.
the latest 13F is the newest step
- period ended2026-06-3013F 4,930 sharesChange vs previous 13F +4,930 shares
0.09% of the 13F portfolio, value $377,737.
13F-HR 0002085853-26-000978 filed by INCEPTIONR LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 0 sharesChange vs previous 13F -3,122 shares
13F-HR 0002085853-26-000252 filed by INCEPTIONR LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-09-3013F 3,122 sharesChange vs previous 13F +268 shares
0.06% of the 13F portfolio, value $268,523.
13F-HR 0002085853-25-000272 filed by INCEPTIONR LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 2,854 sharesChange vs previous 13F +2,854 shares
0.06% of the 13F portfolio, value $242,961.
13F-HR 0001667731-25-001097 filed by INCEPTIONR LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 0 sharesChange vs previous 13F -3,323 shares
13F-HR 0001667731-25-000611 filed by INCEPTIONR LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2024-12-3113F 3,323 sharesChange vs previous 13F not available
0.07% of the 13F portfolio, value $310,435.
13F-HR 0001667731-25-000215 filed by INCEPTIONR LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).